These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9354925)

  • 21. Hereditary colorectal cancer syndromes.
    Guanti G; Bukvić N
    Acta Chir Iugosl; 2000; 47(4 Suppl 1):23-5. PubMed ID: 11432238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rectal cancer--from genetics to the therapy.
    Milosavljevic T
    Acta Chir Iugosl; 1998; 45(2 Suppl):23-7. PubMed ID: 10951782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intervention and follow-up on human esophageal precancerous lesions in Henan, northern China, a high-incidence area for esophageal cancer.
    Wang LD; Zhou Q; Feng CW; Liu B; Qi YJ; Zhang YR; Gao SS; Fan ZM; Zhou Y; Yang CS; Wei JP; Zheng S
    Gan To Kagaku Ryoho; 2002 Feb; 29 Suppl 1():159-72. PubMed ID: 11890101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physical activity and cancer prevention: from observational to intervention research.
    Friedenreich CM
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):287-301. PubMed ID: 11319168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of molecular markers to predict malignant potential of oral precancer.
    Warnakulasuriya S
    J Pathol; 2000 Mar; 190(4):407-9. PubMed ID: 10699986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hereditary colorectal cancer associated with polyposis syndromes].
    Soravia C; Pocard M
    Ann Chir; 1999; 53(10):979-84. PubMed ID: 10670145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular and phenotypic markers of hamartomatous polyposis syndromes in the gastrointestinal tract.
    Entius MM; Westerman AM; van Velthuysen ML; Wilson JH; Hamilton SR; Giardiello FM; Offerhaus GJ
    Hepatogastroenterology; 1999; 46(26):661-6. PubMed ID: 10370593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast cancer and neoadjuvant therapy: any predictive marker?
    Vyzula R; Dusek L; Zaloudík J; Demlová R; Klimes D; Selvekerová S
    Neoplasma; 2004; 51(6):471-80. PubMed ID: 15640958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.
    Syrjänen KJ
    Scand J Infect Dis Suppl; 2009; 107():3-32. PubMed ID: 19408160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Precancerous lesions of the buccal mucosa].
    Ben Slama L
    Rev Stomatol Chir Maxillofac; 2001 Apr; 102(2):77-108. PubMed ID: 11446145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Focus on colorectal adenomas--therapeutic possibilities in precancerous changes and conditions of the colon and rectum in our daily practice]].
    Popovits J; Rosta I
    Orv Hetil; 2003 Aug; 144(35):1707-11. PubMed ID: 14533351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pilot study to establish a clinical model to perform phase II studies of breast cancer chemopreventive agents in women at high risk with biomarkers as surrogate endpoints for activity.
    Stearns V; Gallagher A; Kleer CG; Singh B; Freedman M; Haddad BR; Isaacs C; Warren R; Brown M; Cullen J; Trock B; Hayes DF
    Clin Cancer Res; 2004 Dec; 10(24):8332-40. PubMed ID: 15623610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diet and cancer: the disconnect between epidemiology and randomized clinical trials.
    Meyskens FL; Szabo E
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1366-9. PubMed ID: 15941942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality control for HPLC assay and surrogate end point biomarkers from the fenretinide (4-HPR) breast cancer prevention trial.
    Formelli F
    J Cell Biochem Suppl; 2000; 34():73-9. PubMed ID: 10762018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.